Compare Eni SpA (E) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Zoetis Inc — how do they compare? Eni SpA trades at $55.38 (market cap $80.32B), while Zoetis Inc trades at $72.72 (market cap $31.14B). The key difference: Eni SpA is far larger — about 2.6× Zoetis Inc's market cap, and Eni SpA pays the higher dividend (4.4%). Which is the better fit depends on your goals.
| E | ZTS | |
|---|---|---|
Market Cap | $80.32B | $31.14B |
Sector | Energy | Health |
52-Week High | $57.61 | $156.76 |
52-Week Low | $34.03 | $71.91 |
Enterprise Value | $105.61B | $38.70B |
Dividend Yield | 4.4% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $54.87, up 2.35% today, with a bullish technical signal from moving averages. The stock shows attractive valuation multiples, including a P/E of 12.5 and P/S of 0.82, while recent earnings have been mixed with Q2 2026 missing estimates despite 21.5% revenue growth. Strong cash flow from operations of $13.33 billion in 2025 supports shareholder returns, including a recently increased share buyback program.
The outlook is cautiously optimistic, with production growth and strategic partnerships offering upside, but commodity price volatility and recent earnings misses present risks. Analyst sentiment is mixed, with a 'Moderate Buy' consensus but a majority of holds, reflecting balanced near-term prospects amid energy market uncertainties.
Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.
The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
